Key Aspects of Analytical Development In-House Training
Key elements for a successful development of a drug product analytical development
The analytical aspects of the control strategy will be covered as well analytical documents for the submission.
Overview
The field of analytical development as part of the development of a new or generic drug product covers a huge range from the translation of the Quality Target Product Profile (QTPP) into the Analytical Target Profile (ATP) over the entire analytical procedure life cycle (i.e., development, validation, transfer, and maintenance of new analytical procedures) to key contribution to the control strategy of the commercial product (including definition of Critical Quality Attributes (CQAs), establishing of specification and justification for specification). In addition to these key elements for a successful development of a drug product analytical development is a key player in the stability studies and for the definition of the shelf-life of the medicinal product. Several regulatory documents are around analytical development which provide guidance to the key elements to this CMC topic such as the ICH guidelines for Pharmaceutical Development (Q8 (R2)), Analytical Development (Q14), Method Validation (Q2 (R2)), Specification (Q6A & Q6B), Impurities of new drug substances and products (Q3A & Q3B), and Stability testing (Q1A to Q1E). In addition, further scientific information can be found in pharmacopeial general chapters of the USP. These guidance documents form the basis of this in-house training around analytical development. In detail, the focus of this in-house training is on the specification of drug substances and products and its justification, determination of Critical Quality Attributes (CQAs), life cycle of analytical procedures, analytical documentation in terms of procedure content and validation / transfer of methods, and stability studies for drug substances and products. Furthermore, the analytical aspects of the control strategy will be covered as well analytical documents for the submission.
#inhouse #inhousetraining #glceurope #pharmainhousetraining #globalleadingconferences #keyaspects #analyticaldevelopment
RECOMMENDATION
Who should attend?
Analytical Development
Formulation Development
Project Management
Pre-clinical Development
Clinical Development
CMC Regulatory Affairs
Quality Control
Quality Assurance
Drug Substance Manufacture
Drug Product Manufacture
Testimonial
Our success stories
"High attention to detail in course content and very well delivered"
Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom
Our success stories
"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"
Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland
Our success stories
"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"
Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany
About GLC
Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today its an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.
know more >13+
Years of experience
500+
Events organized
3,970
Speakers
23,714
Attendees
Other events you may like
Artificial Intelligence (AI) as Medical Device MasterClass - EU edition
04-05 November, 2024
Gain invaluable insights into the development, regulation, and deployment of AI-powered medical devices
learn more >>Pharmacovigilance on the Internet and Social Media MasterClass - EU edition
04-06 November, 2024
Pharmaceutical companies and patients/users interact through theInternet,Social media,and two-way communication.
learn more >>Pharmacovigilance on the Internet and Social Media MasterClass - US edition
04-06 November, 2024
Pharmaceutical companies and patients/users interact through theInternet,Social media,and two-way communication.
learn more >>